Jason Hannon

7 results

Shares in Mainstay Medical, the Irish medical device company targeting chronic back pain, crashed to record lows after a key clinical trial failed.

Shares in Mainstay Medical, the Irish medical device company targeting chronic back pain, crashed to record lows after a key clinical trial failed. M(...)

The ReActiv8 unit is designed to treat disabling pain in patients with chronic lower back pain through the use of an implant that stimulates nerves to strengthen muscles in the lower back

Mainstay Medical expects results from a critical trial for its Reactiv8 device for people who suffer disabling chronic lower back pain by the end of t(...)

Matthew Onaitis assumed the role of chief financial officer at Mainstay Medical on August 20th.

Irish-headquartered medical device company Mainstay Medical has appointed Matthew Onaitis as chief financial officer, assuming the role from Hugh Kava(...)

The ReActiv8 unit is designed to treat disabling pain in patients with chronic lower back pain through the use of an implant that stimulates nerves to strengthen muscles in the lower back

Back pain group Mainstay Medical has successfully implanted 204 patients with its Reactiv8 device as part of a clinical trial to access the key United(...)

ReActiv8 is designed to treat chronic low back pain

Irish medical device firm Mainstay Medical International has raised €30.1 million through a new share placing as it pushes to commercialise its back (...)

Mainstay Medical’s  ReActiv8 device for the treatment of chronic low back pain

Mainstay Medical has passed an “important milestone” on winning access to the key US market for its new implant therapy for people suffering from chro(...)

Mainstay Medical chief executive Peter Crosby; he  will stand down in October of this year. Photograph: Nick Bradshaw

Losses at Dublin-based Mainstay Medical have continued to mount for the first half of 2017. The group reported a loss of $13.27 million (€11.17m) fo(...)